hotspot -WSS

hotspot

author：leisure time 2025-09-30 00:51:40 - browse：6

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： The system is set up to fail children with medical complexity

WSS

Medicare Advantage proposed rates disappoint insurers

To avoid data mishandling cases, universities eye AI and other tools

Private equity deals in Medicare Advantage declines

To avoid data mishandling cases, universities eye AI and other tools

What should King Charles tell the public about his cancer?

Industry veterans launch new biotech VC with $310M

focus

hotspot

Sign up for Morning Rounds

hotspot

Continuity nursing helped my family in our darkest PICU moments

How faith leaders like me can help address America's obesity epidemic

Dobbs anniversary: the lost opportunity of abortion as health care

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Walensky prepares to leave CDC — and Congress — behind

BioAge raises $170M for combination therapy with Zepbound

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Gilead might be held responsible for not developing a drug

Drug repurposing or repositioning? The language matters

The system is set up to fail children with medical complexity

hotspot

What we’ve learned from the Aduhelm mess

Cigna wins case to block Amy Bricker's move to CVS

Teladoc has a new CEO, but challenges remain the same

ALS patient reclaims some autonomy thanks to wearable 'robot'

Medicare Advantage proposed rates disappoint insurers

The dental labor crisis is a moment of opportunity

knowledge

focus

knowledge

leisure time